Ansbert Gadicke's Net Worth

$1.04 Billion

Estimate Recalculated Feb 23, 2024 07:02PM EST

Who is Ansbert Gadicke?

Ansbert Gadicke has an estimated net worth of $1.04 Billion. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., EnteroMedics Inc, iTeos Therapeutics, Inc., ARYx Therapeutics, Inc., PEPLIN INC, Restore Medical, Inc., CRYOCOR INC, VIACELL INC, HEMOSENSE INC, COTHERIX INC, Omrix Biopharmaceuticals, Inc., TERCICA INC, BARRIER THERAPEUTICS INC, TriVascular Technologies, Inc., RIGEL PHARMACEUTICALS INC, Cullinan Oncology, Inc., Radius Health, Inc., Entrada Therapeutics, Inc., Repare Therapeutics Inc., Dyne Therapeutics, Inc., Allovir, Inc., Verastem, Inc., Syndax Pharmaceuticals Inc, PHARMATHENE, INC, AVEO PHARMACEUTICALS INC, Pacira Pharmaceuticals, Inc., XCYTE THERAPIES INC, PONIARD PHARMACEUTICALS, INC., Harpoon Therapeutics, Inc., ACORDA THERAPEUTICS INC, ARATANA THERAPEUTICS, INC., KALOBIOS PHARMACEUTICALS INC, TCR2 THERAPEUTICS INC., Conatus Pharmaceuticals Inc, Epizyme, Inc., Werewolf Therapeutics, Inc., Cerecor Inc., Oncorus, Inc., CRITICAL THERAPEUTICS INC, Pharmasset Inc, Zalicus Inc., AFFYMAX INC, CHIASMA, INC, Somaxon Pharmaceuticals, Inc., IDENIX PHARMACEUTICALS INC, HELICOS BIOSCIENCES CORP, SENORX INC, OSCIENT PHARMACEUTICALS CORP, Alsius Corp, MEMORY PHARMACEUTICALS CORP, and METABASIS THERAPEUTICS INC.

SEC CIK

Ansbert Gadicke's CIK is 0001134655

Past Insider Trading and Trends

2020 was Ansbert Gadicke's most active year for acquiring shares with 41 total transactions. Ansbert Gadicke's most active month to acquire stocks was the month of January. 2021 was Ansbert Gadicke's most active year for disposing of shares, totalling 234 transactions. Ansbert Gadicke's most active month to dispose stocks was the month of May. 2019 saw Ansbert Gadicke paying a total of $27,627,508.38 for 15,328,700 shares, this is the most they've acquired in one year. In 2007 Ansbert Gadicke cashed out on 44,342,084 shares for a total of $97,991,841.52, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $47.9

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+9,078.27%
2.67M
$17.00
2.7M
Oct 10
Form 3
0
0
No matching records found

EnteroMedics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+73.01%
704.61K
1.67M
Dec 14
Form 4
0
0
Sep 30
Form 4
+43.86%
1.77M
$1.15
$2,030,323.85
5.79M
Feb 24
Form 4
4.03M
$8.00
4.03M
Nov 20
Form 3
0
0
No matching records found

iTeos Therapeutics, Inc. (ITOS) Snapshot price: $9.99

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.19%
-245.47K
$42.58
-$10,452,333.95
4.48M
Jan 4 - Jan 5
Form 4
-1.73%
-83.39K
$33.73
-$2,812,427.53
4.73M
Scheduled
Dec 3 - Dec 7
Form 4
-2.82%
-139.77K
$34.47
-$4,817,417.25
4.81M
Scheduled
Nov 30 - Dec 2
Form 4
-0.77%
-38.57K
$35.18
-$1,356,824.98
4.95M
Scheduled
Nov 26 - Nov 29
Form 4
-0.95%
-145.29K
$36.85
-$4,744,666.44
15.22M
Scheduled
Nov 17 - Nov 24
Form 4
-0.55%
-28.61K
$27.45
-$785,384.39
5.14M
Scheduled
Oct 15 - Oct 18
Form 4
-1.81%
-95.00K
$27.21
-$2,584,606.09
5.17M
Scheduled
Oct 12 - Oct 14
Form 4
-1.63%
-87.01K
$27.23
-$2,368,800.16
5.26M
Scheduled
Oct 7 - Oct 11
Form 4
-0.86%
-46.13K
$27.05
-$1,247,589.54
5.35M
Scheduled
Oct 1 - Oct 4
Form 4
-0.66%
-35.99K
$27.00
-$971,730.00
5.39M
Scheduled
Sep 28 - Sep 30
Form 4
-1.62%
-89.48K
$27.76
-$2,484,093.96
5.43M
Scheduled
Sep 23 - Sep 27
Form 4
-1.02%
-56.78K
$27.50
-$1,561,393.60
5.52M
Scheduled
Sep 21 - Sep 22
Form 4
-2.67%
-152.71K
$28.38
-$4,334,451.90
5.58M
Scheduled
Sep 16 - Sep 20
Form 4
-1.32%
-76.42K
$27.70
-$2,116,733.05
5.73M
Scheduled
Sep 14 - Sep 15
Form 4
-1.63%
-96.46K
$28.32
-$2,731,459.64
5.81M
Scheduled
Sep 9 - Sep 13
Form 4
-1.71%
-102.57K
$29.03
-$2,067,786.01
5.9M
Scheduled
Sep 7 - Sep 8
Form 4
-0.00%
-200.00
$29.99
-$5,998.00
6M
Scheduled
Apr 9
Form 4
-0.95%
-57.65K
$30.99
-$1,300,850.41
6M
Scheduled
Apr 7 - Apr 8
Form 4/A
0
0
Jul 23
Form 4
+64.51%
6.06M
$19.00
$6,080,000.00
15.46M
Jul 28
Form 4
0
0
Jul 23
Form 3
0
0
No matching records found

ARYx Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Sep 30
Form 4
0
0
Aug 13
Form 4
+49.98%
1.79M
$2.20
$3,932,962.00
5.36M
Nov 14
Form 4
3.58M
$10.00
3.58M
Nov 13
Form 3
0
0
No matching records found

PEPLIN INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.42M
0
Nov 11
Form 4
+0.07%
2.25K
$8.11
$18,233.80
3.42M
Feb 11 - Feb 12
Form 4
+0.03%
1K
$8.00
$7,992.00
3.42M
Feb 9
Form 4
+0.08%
2.65K
$7.80
$20,654.40
3.42M
Feb 5
Form 4
+0.23%
7.71K
$8.04
$61,948.00
3.41M
Jan 23 - Jan 27
Form 4
+0.10%
3.52K
$8.07
$28,369.80
3.41M
Jan 21 - Jan 22
Form 4
+0.29%
9.88K
$8.14
$80,402.20
3.4M
Jan 15 - Jan 20
Form 4
+0.20%
6.91K
$7.03
$48,584.33
3.39M
Jan 13
Form 3/A
0
0
Form 3
0
0
No matching records found